Aida Kondybayeva
Overview
Explore the profile of Aida Kondybayeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leonardi M, Colonna I, Garcia-Azorin D, Bereczki D, Bodini B, Bregman N, et al.
Eur J Neurol
. 2024 Oct;
31(12):e16516.
PMID: 39429124
Background And Purpose: The European Academy of Neurology (EAN) has adhered to the global plan for reducing the burden of neurological disorders and promoting brain health launched by the World...
2.
Feigin V, Martins S, Brainin M, Norrving B, Kamenova S, Giniyat A, et al.
Eur J Neurol
. 2023 Nov;
31(3):e16157.
PMID: 38009814
Background And Purpose: Early this century, the high risk strategy of primary stroke and cardiovascular disease (CVD) prevention for individuals shifted away from identifying (and treating, as appropriate) all at-risk...
3.
Rakhmetullina A, Akimniyazova A, Niyazova T, Pyrkova A, Kamenova S, Kondybayeva A, et al.
Curr Issues Mol Biol
. 2023 May;
45(4):2950-2964.
PMID: 37185717
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused the COVID-19 pandemic, can still infect populations in many countries around the globe. The Omicron strain is the most mutated variant...
4.
Kamenova S, Sharapkhanova A, Akimniyazova A, Kuzhybayeva K, Kondybayeva A, Rakhmetullina A, et al.
Nanomaterials (Basel)
. 2023 Jan;
13(1).
PMID: 36615932
Multiple sclerosis (MS) is a common inflammatory demyelinating disease with a high mortality rate. MS is caused by many candidate genes whose specific involvement has yet to be established. The...
5.
Sasanejad P, Afshar Hezarkhani L, Arsang-Jang S, Tsivgoulis G, Ghoreishi A, Barlinn K, et al.
J Stroke Cerebrovasc Dis
. 2021 Oct;
30(12):106121.
PMID: 34601242
Background: There is little information regarding the safety of intravenous tissue plasminogen activator (IV-tPA) in patients with stroke and COVID-19. Methods: This multicenter study included consecutive stroke patients with and...
6.
Kamenova S, Aralbayeva A, Kondybayeva A, Akimniyazova A, Pyrkova A, Ivashchenko A
Front Genet
. 2021 Apr;
12:647288.
PMID: 33859673
Parkinson's disease (PD) exhibits the second-highest rate of mortality among neurodegenerative diseases. PD is difficult to diagnose and treat due to its polygenic nature. In recent years, numerous studies have...
7.
Nogueira R, Qureshi M, Abdalkader M, Martins S, Yamagami H, Qiu Z, et al.
Neurology
. 2021 Mar;
96(23):e2824-e2838.
PMID: 33766997
Objective: To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March...
8.
Ghoreishi A, Arsang-Jang S, Sabaa-Ayoun Z, Yassi N, Sylaja P, Akbari Y, et al.
J Stroke Cerebrovasc Dis
. 2020 Oct;
29(12):105321.
PMID: 33069086
Background: The emergence of the COVID-19 pandemic has significantly impacted global healthcare systems and this may affect stroke care and outcomes. This study examines the changes in stroke epidemiology and...
9.
Kondybayeva A, Akimniyazova A, Kamenova S, Duchshanova G, Aisina D, Goncharova A, et al.
Neurol Sci
. 2019 Dec;
41(4):799-808.
PMID: 31784845
Background: The role of miRNA in tissue affected by stroke is actively studied, but it remains unclear which miRNAs and target genes are involved in the development of stroke. Methods:...